Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037812 · ClinicalTrials.gov registry record · Early Phase 1
Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures
A Early Phase 1 study of Tibial Plateau Fractures, sponsored by University of Utah.
- Active
- Registry status
- Early Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05037812 is a Early Phase 1 study of Tibial Plateau Fractures that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05037812, a Early Phase 1 study of Tibial Plateau Fractures, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators goal of the proposed research study is to determine the effectiveness of periarticular multimodal analgesia in the setting of tibial plateau fractures. Effectiveness of the multimodal analgesia is defined as lower pain scores.
Conditions Studied
Interventions
- DRUG Saline injection
- DRUG Multimodal injections
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2026-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05037812
The ClinicalTrials.gov registry entry for NCT05037812 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tibial Plateau Fractures appearing as the primary indexed condition, and to 2 interventions - of which Saline injection is the first listed.
NCT05037812 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05037812 about?
NCT05037812 is a clinical study titled "Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures". The investigators goal of the proposed research study is to determine the effectiveness of periarticular multimodal analgesia in the setting of tibial plateau fractures. Effectiveness of the multimodal analgesia is defined as lower pain scores.
What is the current status of trial NCT05037812?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 150 participants. The study started on 2019-03-25. Estimated completion is 2026-03.
What conditions does trial NCT05037812 study?
This clinical trial studies the following conditions: Tibial Plateau Fractures.
What interventions are being tested in trial NCT05037812?
The interventions under investigation include: Saline injection (DRUG), Multimodal injections (DRUG).
Who is sponsoring clinical trial NCT05037812?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05037812 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tibial Plateau Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.